Literature DB >> 25662988

Reduction in coronary microvascular resistance through cardiac resynchronization and its impact on chronic reverse remodelling of left ventricle in patients with non-ischaemic cardiomyopathy.

Mitsuaki Itoh1, Toshiro Shinke2, Akihiro Yoshida1, Amane Kozuki1, Asumi Takei1, Koji Fukuzawa1, Kunihiko Kiuchi1, Kimitake Imamura1, Ryudo Fujiwara1, Atsushi Suzuki1, Tomoyuki Nakanishi1, Soichiro Yamashita1, Akinori Matsumoto1, Hiromasa Otake1, Ryoji Nagoshi1, Junya Shite1, Ken-ichi Hirata1.   

Abstract

AIMS: Left bundle branch block (LBBB) induces mechanical dyssynchrony, thereby compromising the coronary circulation in non-ischaemic cardiomyopathy. We sought to examine the effects of cardiac resynchronization therapy (CRT) on coronary flow dynamics and left ventricular (LV) function. METHODS AND
RESULTS: Twenty-two patients with non-ischaemic cardiomyopathy (New York Heart Association class, III or IV; LV ejection fraction, ≤35%; QRS duration, ≥130 ms) were enrolled. One week after implantation of the CRT device, coronary flow velocity and pressure in the left anterior descending coronary artery (LAD) and left circumflex coronary artery (LCx) were measured invasively, before and after inducing hyperemia by adenosine triphosphate administration, with two programming modes: sequential atrial and biventricular pacing (BiV) and atrial pacing in patients with LBBB or sequential atrial and right ventricular pacing in patients with complete atrioventricular block (Control). We assessed hyperemic microvascular resistance (HMR, mean distal pressure divided by hyperemic average peak velocity) and the relationship between the change in HMR and mid-term LV reverse remodelling. Hyperemic microvascular resistance was lower during BiV than during Control (LAD: 1.76 ± 0.47 vs. 1.54 ± 0.45, P < 0.001; LCx: 1.92 ± 0.42 vs. 1.73 ± 0.31, P = 0.003). The CRT-induced change in HMR of the LCx correlated with the percentage change in LV ejection fraction (R = -0.598, P = 0.011) and LV end-systolic volume (R = 0.609, P = 0.010) before and 6 months after CRT.
CONCLUSION: Cardiac resynchronization therapy improves coronary flow circulation by reducing microvascular resistance, which might be associated with LV reverse remodelling. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Biventricular pacing; Cardiac resynchronization therapy; Coronary circulation; Coronary microvascular resistance; Nonischaemic cardiomyopathy

Mesh:

Year:  2015        PMID: 25662988     DOI: 10.1093/europace/euu361

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

1.  Assessment of coronary flow reserve predicts long-term outcome of responders to cardiac resynchronization therapy.

Authors:  Kunio Yufu; Hidekazu Kondo; Tetsuji Shinohara; Yumi Ishii; Seiichiro Yoshimura; Ichitaro Abe; Shotaro Saito; Akira Fukui; Norihiro Okada; Hidefumi Akioka; Yasushi Teshima; Mikiko Nakagawa; Naohiko Takahashi
Journal:  Heart Vessels       Date:  2018-11-27       Impact factor: 2.037

2.  Role of coronary flow regulation and cardiac-coronary coupling in mechanical dyssynchrony associated with right ventricular pacing.

Authors:  Lei Fan; Ravi Namani; Jenny S Choy; Yousif Awakeem; Ghassan S Kassab; Lik Chuan Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-12-24       Impact factor: 4.733

3.  The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster.

Authors:  Takashi Kido; Shigeru Miyagawa; Takasumi Goto; Katsuto Tamai; Takayoshi Ueno; Koichi Toda; Toru Kuratani; Yoshiki Sawa
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

4.  Effects of Epicardial and Endocardial Cardiac Resynchronization Therapy on Coronary Flow: Insights From Wave Intensity Analysis.

Authors:  Simon Claridge; Zhong Chen; Tom Jackson; Kalpa De Silva; Jonathan Behar; Manav Sohal; Jessica Webb; Eoin Hyde; Matthew Lumley; Kal Asrress; Rupert Williams; Julian Bostock; Motin Ali; Jaswinder Gill; Mark O'Neill; Reza Razavi; Steve Niederer; Divaka Perera; Christopher Aldo Rinaldi
Journal:  J Am Heart Assoc       Date:  2015-12-17       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.